JAL (RH48) blood group antigen

Serologic observations

Christine Lomas-Francis, Denden Alcantara, Connie Westhoff, Joan Uehlinger, Marilia Valvasori, Lillian Castilho, Marion E. Reid

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND: JAL (RH48) is a low-prevalence antigen in the Rh blood group system and anti-JAL has caused hemolytic disease of the newborn. JAL is associated with either a haplotype carrying depressed C and e antigens or one carrying depressed c and e antigens. Blood samples from JAL+ people were tested, published serologic findings were confirmed, serologic studies were extended to include expression of other Rh antigens, and the antibody specificities produced by three sensitized JAL+ probands are reported. STUDY DESIGN AND METHODS: Red blood cell (RBC) samples from 17 (12 probands) JAL+ persons were tested by hemagglutination using standard methods. RESULTS: RBCs from both the Caucasian JAL+ probands had the (C)(e) haplotype and weakened C, e, hr B, and hrS antigens. JAL+ samples from black persons had the (c)(e) haplotype and expressed weakened c, e, f, V, VS, hrB, and hrS antigens. Plasma from three sensitized c+e+ JAL+ probands contained alloanti-c, alloanti-e, or alloantibody of apparent anti-Rh17 specificity. This study shows that this alloanti-Rh17-like antibody recognizes the high-prevalence antigen antithetical to JAL that has been named CEST. CONCLUSIONS: The presence of the JAL antigen has a quantitative (weakening) effect on the expression of C, e, hrB, and hrS antigens in Caucasian persons and of c, e, f, V, VS, hrB, and hrS antigens in people of black African ancestry. A qualitative effect also was demonstrated by the presence of alloanti-c or alloanti-e in the plasma of two transfused c+e+ patients and by an antibody (anti-CEST) that recognizes the high-prevalence antigen antithetical to JAL.

Original languageEnglish (US)
Pages (from-to)719-724
Number of pages6
JournalTransfusion
Volume49
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Blood Group Antigens
Antigens
Haplotypes
Hepatitis B e Antigens
Fetal Erythroblastosis
Isoantibodies
Antibody Specificity
Hemagglutination
Anti-Idiotypic Antibodies
Erythrocytes
Antibodies

ASJC Scopus subject areas

  • Hematology
  • Immunology
  • Immunology and Allergy

Cite this

Lomas-Francis, C., Alcantara, D., Westhoff, C., Uehlinger, J., Valvasori, M., Castilho, L., & Reid, M. E. (2009). JAL (RH48) blood group antigen: Serologic observations. Transfusion, 49(4), 719-724. https://doi.org/10.1111/j.1537-2995.2008.02025.x

JAL (RH48) blood group antigen : Serologic observations. / Lomas-Francis, Christine; Alcantara, Denden; Westhoff, Connie; Uehlinger, Joan; Valvasori, Marilia; Castilho, Lillian; Reid, Marion E.

In: Transfusion, Vol. 49, No. 4, 04.2009, p. 719-724.

Research output: Contribution to journalArticle

Lomas-Francis, C, Alcantara, D, Westhoff, C, Uehlinger, J, Valvasori, M, Castilho, L & Reid, ME 2009, 'JAL (RH48) blood group antigen: Serologic observations', Transfusion, vol. 49, no. 4, pp. 719-724. https://doi.org/10.1111/j.1537-2995.2008.02025.x
Lomas-Francis C, Alcantara D, Westhoff C, Uehlinger J, Valvasori M, Castilho L et al. JAL (RH48) blood group antigen: Serologic observations. Transfusion. 2009 Apr;49(4):719-724. https://doi.org/10.1111/j.1537-2995.2008.02025.x
Lomas-Francis, Christine ; Alcantara, Denden ; Westhoff, Connie ; Uehlinger, Joan ; Valvasori, Marilia ; Castilho, Lillian ; Reid, Marion E. / JAL (RH48) blood group antigen : Serologic observations. In: Transfusion. 2009 ; Vol. 49, No. 4. pp. 719-724.
@article{375285fb6f1c42cd9a80d1fc3f76fe47,
title = "JAL (RH48) blood group antigen: Serologic observations",
abstract = "BACKGROUND: JAL (RH48) is a low-prevalence antigen in the Rh blood group system and anti-JAL has caused hemolytic disease of the newborn. JAL is associated with either a haplotype carrying depressed C and e antigens or one carrying depressed c and e antigens. Blood samples from JAL+ people were tested, published serologic findings were confirmed, serologic studies were extended to include expression of other Rh antigens, and the antibody specificities produced by three sensitized JAL+ probands are reported. STUDY DESIGN AND METHODS: Red blood cell (RBC) samples from 17 (12 probands) JAL+ persons were tested by hemagglutination using standard methods. RESULTS: RBCs from both the Caucasian JAL+ probands had the (C)(e) haplotype and weakened C, e, hr B, and hrS antigens. JAL+ samples from black persons had the (c)(e) haplotype and expressed weakened c, e, f, V, VS, hrB, and hrS antigens. Plasma from three sensitized c+e+ JAL+ probands contained alloanti-c, alloanti-e, or alloantibody of apparent anti-Rh17 specificity. This study shows that this alloanti-Rh17-like antibody recognizes the high-prevalence antigen antithetical to JAL that has been named CEST. CONCLUSIONS: The presence of the JAL antigen has a quantitative (weakening) effect on the expression of C, e, hrB, and hrS antigens in Caucasian persons and of c, e, f, V, VS, hrB, and hrS antigens in people of black African ancestry. A qualitative effect also was demonstrated by the presence of alloanti-c or alloanti-e in the plasma of two transfused c+e+ patients and by an antibody (anti-CEST) that recognizes the high-prevalence antigen antithetical to JAL.",
author = "Christine Lomas-Francis and Denden Alcantara and Connie Westhoff and Joan Uehlinger and Marilia Valvasori and Lillian Castilho and Reid, {Marion E.}",
year = "2009",
month = "4",
doi = "10.1111/j.1537-2995.2008.02025.x",
language = "English (US)",
volume = "49",
pages = "719--724",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - JAL (RH48) blood group antigen

T2 - Serologic observations

AU - Lomas-Francis, Christine

AU - Alcantara, Denden

AU - Westhoff, Connie

AU - Uehlinger, Joan

AU - Valvasori, Marilia

AU - Castilho, Lillian

AU - Reid, Marion E.

PY - 2009/4

Y1 - 2009/4

N2 - BACKGROUND: JAL (RH48) is a low-prevalence antigen in the Rh blood group system and anti-JAL has caused hemolytic disease of the newborn. JAL is associated with either a haplotype carrying depressed C and e antigens or one carrying depressed c and e antigens. Blood samples from JAL+ people were tested, published serologic findings were confirmed, serologic studies were extended to include expression of other Rh antigens, and the antibody specificities produced by three sensitized JAL+ probands are reported. STUDY DESIGN AND METHODS: Red blood cell (RBC) samples from 17 (12 probands) JAL+ persons were tested by hemagglutination using standard methods. RESULTS: RBCs from both the Caucasian JAL+ probands had the (C)(e) haplotype and weakened C, e, hr B, and hrS antigens. JAL+ samples from black persons had the (c)(e) haplotype and expressed weakened c, e, f, V, VS, hrB, and hrS antigens. Plasma from three sensitized c+e+ JAL+ probands contained alloanti-c, alloanti-e, or alloantibody of apparent anti-Rh17 specificity. This study shows that this alloanti-Rh17-like antibody recognizes the high-prevalence antigen antithetical to JAL that has been named CEST. CONCLUSIONS: The presence of the JAL antigen has a quantitative (weakening) effect on the expression of C, e, hrB, and hrS antigens in Caucasian persons and of c, e, f, V, VS, hrB, and hrS antigens in people of black African ancestry. A qualitative effect also was demonstrated by the presence of alloanti-c or alloanti-e in the plasma of two transfused c+e+ patients and by an antibody (anti-CEST) that recognizes the high-prevalence antigen antithetical to JAL.

AB - BACKGROUND: JAL (RH48) is a low-prevalence antigen in the Rh blood group system and anti-JAL has caused hemolytic disease of the newborn. JAL is associated with either a haplotype carrying depressed C and e antigens or one carrying depressed c and e antigens. Blood samples from JAL+ people were tested, published serologic findings were confirmed, serologic studies were extended to include expression of other Rh antigens, and the antibody specificities produced by three sensitized JAL+ probands are reported. STUDY DESIGN AND METHODS: Red blood cell (RBC) samples from 17 (12 probands) JAL+ persons were tested by hemagglutination using standard methods. RESULTS: RBCs from both the Caucasian JAL+ probands had the (C)(e) haplotype and weakened C, e, hr B, and hrS antigens. JAL+ samples from black persons had the (c)(e) haplotype and expressed weakened c, e, f, V, VS, hrB, and hrS antigens. Plasma from three sensitized c+e+ JAL+ probands contained alloanti-c, alloanti-e, or alloantibody of apparent anti-Rh17 specificity. This study shows that this alloanti-Rh17-like antibody recognizes the high-prevalence antigen antithetical to JAL that has been named CEST. CONCLUSIONS: The presence of the JAL antigen has a quantitative (weakening) effect on the expression of C, e, hrB, and hrS antigens in Caucasian persons and of c, e, f, V, VS, hrB, and hrS antigens in people of black African ancestry. A qualitative effect also was demonstrated by the presence of alloanti-c or alloanti-e in the plasma of two transfused c+e+ patients and by an antibody (anti-CEST) that recognizes the high-prevalence antigen antithetical to JAL.

UR - http://www.scopus.com/inward/record.url?scp=62949192961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62949192961&partnerID=8YFLogxK

U2 - 10.1111/j.1537-2995.2008.02025.x

DO - 10.1111/j.1537-2995.2008.02025.x

M3 - Article

VL - 49

SP - 719

EP - 724

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 4

ER -